Introduction {#s0001}
============

Lung cancer is the most common type of cancer in the world and it is estimated that 242,550 new cases and 163,660 deaths were attributed to lung cancer in the USA in 2014.[@cit0001] Lung cancer includes non-small cell lung carcinoma (NSCLC) and small cell lung carcinoma (SCLC).[@cit0002] SCLC appears to arise from neuroendocrine cells,[@cit0003] whereas NSCLC, which accounts for approximately 85% of all cases, derives from pulmonary epithelial cells.[@cit0004] Its morbidity and mortality have increased rapidly in the past 30 years, particularly in developing countries, such as China.[@cit0005] Unlike many other cancers, the etiological factor of the majority of cases of lung cancer is tobacco consumption and environmental pollution.[@cit0006] Therefore, understanding the factors that predispose an individual to lung cancer is of prime importance. Among lung carcinogens, nickel is classified as group 1 carcinogen (confirmed carcinogen) for humans by International Agency for Research on Cancer in 1990.[@cit0008] Nickel is abundant in metallurgy waste air, burning fossil fuels, and cigarette smoke.[@cit0009] Increased mortality from lung malignant tumors has been found in nickel refinery workers who are exposed daily to nickel-contaminated air.[@cit0010] The carcinogenic effects of nickel are also supported by results observed in human epidemiological investigation, in vitro cell transformation studies and *in vivo* animal experiments.[@cit0011] The association between lung inflammation and lung cancer development is supported by at least 10 cohort studies and animal studies.[@cit0014] And although the chronic lung inflammatory microenvironment is accepted to be a major driving force for the development of lung cancers from the inflammatory process,[@cit0015] it is still unclear how chronic nickel exposure results in chronic lung inflammation and how chronic lung inflammation develops into tumors.

SQSTM1/p62 (sequestosome 1) is a multifunctional protein, and acts as a scaffold for intracellular signaling that controls bone remodeling, obesity and smooth muscle proliferation.[@cit0017] It has been reported that sustained SQSTM1 expression resulting from autophagy defects leads to NFKB activation and gene expression, which in turn promotes tumorigenesis in mouse models.[@cit0020] Paradoxically, SQSTM1 synergizes with autophagy for tumor growth *in vivo*[@cit0021] and the knockdown of *SQSTM1* shows significant inhibitory effects on autophagy activation and tumor growth of human colon cancer cells both in vitro and in a xenograft tumor model.[@cit0022] Thus, the biological role of SQSTM1 in cancer is far from understood. Although SQSTM1 upregulation has been reported to be associated with poor prognosis in patients with lung adenocarcinoma,[@cit0023] nothing is known about the effect of exposure to environmental carcinogens on SQSTM1 expression. More importantly, nothing is known about the relationship between SQSTM1 upregulation and TNF overexpression, or the upstream regulators and/or downstream effectors that induce TNF expression and cause human bronchial epithelial cell transformation upon environmental carcinogen exposure. Thus, we explored the potential effects of nickel exposure on SQSTM1 expression, autophagy activation, and the relationship between SQSTM1 expression, autophagy activation and inflammatory TNF expression, as well as cell transformation in human bronchial epithelial cells following nickel exposure in the current studies. Moreover, our important findings were also applicable to an *in vivo* animal model.

Results {#s0002}
=======

Upregulation of SQSTM1 expression was observed as a result of nickel exposure both in vitro and in vivo, and in human lung cancer tissues.

Although SQSTM1 overexpression has been reported in some cancer tissues,[@cit0023] to the best of our knowledge, its potential induction in lung carcinogenesis due to environmental lung carcinogen exposure have never been explored. Although lung inflammation involves events from inflammatory cells, such as macrophages and leukocytes, the lung epithelial cells are the cells that are first exposed and respond to nickel exposure. Therefore, the current studies, focused on the effects of nickel exposure in human lung epithelial cells. Since the Occupational Safety and Health Administration permissible exposure limit is 1 mg Ni/m^3^, the in vitro dose of nickel chloride at 1.0 mM is equivalent to the same alveolar dose of a human exposed to this limit for 8 h with light work.[@cit0024] We also performed a colony-survival assay to determine the cytotoxic effects of 1.0 mM nickel on Beas-2B cells, and the results indicated that there were no significant inhibition of colonies in Beas-2B cells following nickel exposure as shown in Fig. S1. To test the effects of nickel exposure in human lung epithelial cells, Beas-2B cells were exposed to NiCl~2~, and SQSTM1 protein expression was assessed by western blot. As shown in [Figure 1A and 1B](#f0001){ref-type="fig"}, nickel exposure (1.0 mM) resulted in a significant upregulation of SQSTM1 protein expression. We further extended our observation of nickel upregulation of SQSTM1 protein to normal human bronchial epithelial cells (NHBECs) and human bronchial epithelial BEP2D cells (Fig. S2). It has been reported that SQSTM1 exhibits its function mostly acting as a scaffold for intracellular signaling.[@cit0025] To understand the potential SQSTM1 cellular location following nickel exposure, *GFP-SQSTM1* was stably transfected into Beas-2B cells and stable transfectant Beas-2B(*GFP-SQSTM1*) was established, as identified ([Fig. 1C](#f0001){ref-type="fig"}). Beas-2B(*GFP-SQSTM1*) was then exposed to nickel and the dynamic distribution of GFP-SQSTM1 was observed in various time points following nickel exposure under a Leica fluorescence microcope. The results showed that GFP-SQSTM1 was mainly present in the cytoplasm in Beas-2B cells without nickel exposure, whereas nickel exposure resulted in GFP-SQSTM1 fluorescence puncta in a time-dependent manner ([Fig. 1D](#f0001){ref-type="fig"}). These results reveal that SQSTM1 protein upregulation might be associated with its biological function in cells due to nickel exposure. Figure 1.Upregulation of SQSTM1 expression by nickel in vitro and *in vivo*, as well as SQSTM1 overexpression in human lung cancer tissues. (A and B) 2×10^5^ of Beas-2B cells were seeded into each well of 6-well plates. After the cell density reached 80∼90%, the cells were exposed to 1.0 mM NiCl~2~ for the various time points indicated. The cells were then extracted with an SDS-sample buffer (10 mM Tris-HCl, pH 7.4, 1% SDS, 1mM Na~3~VO~4~, and 1× complete protease inhibitor) and cell extracts were subjected to protein gel blot. ACTB was used as a control for protein loading. The data shown in (A) are representative of 3 independent experiments, and the SQSTM1 expression band was quantitatively analyzed by using prism software and presented in (B). (C) Beas-2B GFP-SQSTM1 stable transfectants were identified with western blotting; primary antibodies against GFP or SQSTM1 were used to determine exogenous GFP-SQSTM1 expression. (D) Beas-2B(*GFP-SQSTM1*) cells (1×10^4^) were seeded into each well of an 8-well chamber. Following culturing at 37°C for 48 h, the cells were treated with 1.0 mM NiCl~2~ for the time points indicated, and the GFP-SQSTM1 distributions in Beas-2B cells were captured using fluorescence microscopy. (E-G) C57BL/6J mice were exposed to nickel nanoparticles *via* inhalation for 24 h or 48 h (E) or 5-months (F). Lung tissues were extracted for protein extracts and the extracts were subjected to western blot. ACTB was used as a protein loading control. (G) Seven pairs of human primary lung cancers and their adjacent normal lung tissues were obtained from the First Affiliated Hospital of Wenzhou Medical University; the tissue extracts were subjected to western blotting and TUBA was used as a protein loading control.

Although it is easy to use soluble nickel compound for mechanistic in vitro studies, nano-Ni-hydroxide would be more realistic in reflecting the real world exposure scenarios for *in vivo* experiments.[@cit0024] To evaluate the *in vivo* effect of nickel on SQSTM1 expression, we exposed C57BL/6J mice to nanoparticle nickel *via* inhalation for the indicated time points. The lung tissues from exposed mice were extracted for determination of SQSTM1 protein expression. The results obtained from protein gel blotting showed that SQSTM1 expression was significantly upregulated in mouse lung tissues following nickel exposure as early as 48 h post-exposure ([Fig. 1E](#f0001){ref-type="fig"}) and that there were sustained increases in mouse lung tissues (6 of 7 mice) following nickel exposure for 5 months, in comparison to the lung tissues obtained from control particle-exposed mice in all of 7 mice examined ([Fig. 1F](#f0001){ref-type="fig"}). These results demonstrate that nickel is capable of upregulating SQSTM1 protein expression both in vitro and in vivo. To determine whether SQSTM1 upregulation is relevant to human lung carcinoma development, we extended our observation to human lung cancer tissues. Since the nickel exposure is associated with lung squamous cell carcinoma development,[@cit0026] we evaluated SQSTM1 expression in lung tissues from the patients with human lung squamous cell carcinoma. As shown in [Figure 1G](#f0001){ref-type="fig"}, SQSTM1 upregulation was observed in 3 (\#4, \#5, \#7) of the 7 cases of lung squamous cell carcinoma patients (Table S1) as compared with that of the corresponding adjacent normal lung tissues. Collectively, our results demonstrate that SQSTM1 upregulation is not only observed in human lung epithelial cells and in mouse lung tissues following nickel exposure, but also exhibits in human lung cancer tissues.

SQSTM1 upregulation plays an important role in nickel-induced malignant transformation of human bronchial epithelial cells.

To determine whether SQSTM1 upregulation played an important role in nickel-induced carcinogenic effects, 3 shRNAs (short hairpin RNA) specifically targeting different sequences of human *SQSTM1* were stably transfected into Beas-2B cells with puromycin selection, and Beas-2B *shSQSTM1* stable transfectants, Beas-2B(*shSQSTM1-\#1*), Beas-2B(*shSQSTM1-\#2*) and Beas-2B(*shSQSTM1-\#3*) were established. As shown in [Figure 2A](#f0002){ref-type="fig"}, the stable transfection of either one of 3 shRNAs that specially target different sequence of *SQSTM1* mRNA dramatically knocked down SQSTM1 protein expression in Beas-2B cells in comparison to Beas-2B(*Nonsense*) transfectant. The repeated exposure of these transfectants to nickel resulted in Beas-2B(*Nonsense*) transfectant cells gaining the capability of anchorage-independent growth in soft agar, a hallmark of cellular malignant transformation. Knockdown of *SQSTM1* expression led to a significant inhibition of Beas-2B cell transformation by nickel compared to the Beas-2B(*Nonsense*) transfectant under the same experimental conditions ([Fig. 2B and 2C](#f0002){ref-type="fig"}). Consistently, ectopic expression of GFP-SQSTM1 in Beas-2B cells significantly increased nickel-induced cell transformation in comparison with Beas-2B(*Vector*) cells ([Fig. 2D and 2E](#f0002){ref-type="fig"}). The Beas-2B cell line is a human bronchial epithelial cell line that has been immortalized by overexpression of SV40 large T antigen.[@cit0027] To exclude the possibility that nickel-induced cell transformation was mediated by nickel upregulation of *Large T antigen* gene, we evaluated the potential effect of nickel on *Large T antigen* expression in Beas-2B. The results showed that nickel exposure did not exhibit upregulation of *Large T antigen* in Beas-2B cells (Fig. S3). Moreover, we employed a second human bronchial epithelial cell line, BEP2D, which is immortalized by human papillomavirus.[@cit0028] The results showed a similar effect of SQSTM1 upregulation upon nickel exposure, whereas knockdown of *SQSTM1* in BEP2D cells also attenuated nickel-induced cell transformation in [Figure 2F-2H](#f0002){ref-type="fig"}. Taken together, our results strongly demonstrate that SQSTM1 upregulation contributes to human bronchial epithelial cell malignant transformation due to nickel exposure. Figure 2.SQSTM1 upregulation played an important role in nickel-induced malignant transformation of human bronchial epithelial cells. (A and F) *shSQSTM1-\#1, shSQSTM1-\#2*, and *shSQSTM1-\#3* represent different shRNAs that specifically target 3 different sequences in *SQSTM1* mRNA and its nonsense vector were stably transfected into Beas-2B cells (A) or BEP2D cells (F), respectively, and their stable transfectants were established and identified by western blot with specific anti-SQSTM1 antibody. (B and C) Beas-2B(*Nonsense*), Beas-2B(*shSQSTM1-\#1*) and Beas-2B(*shSQSTM1-\#3*) cells were repeatedly exposed to 0.5 mM NiCl~2~ for 6 months and then subjected to soft agar assay. The cell colonies were counted by microscopy. Each bar indicates the mean and SD from triplicate assays. The symbol (\*) indicates a significant increase as compared with the medium control (*p* \< 0.05), while the symbol (♣) indicates a significant decrease as compared with the Beas-2B (*Nonsense*) cells (*p* \< 0.05). (D and E) Beas-2B(*GFP*) and Beas-2B(*GFP-SQSTM1*) cells were repeatedly exposed to 0.5 mM NiCl~2~ for 5 months and then subjected to the soft agar assay. Each bar indicates the mean and SD from triplicate assays. The symbol (\*) indicates a significant increase in comparison to the Beas-2B(*GFP*) control (*p* \< 0.05). (G and H) BEP2D(*Nonsense*), BEP2D(*shSQSTM1-\#1*) and BEP2D(*shSQSTM1-\#3*) cells were repeatedly exposed to 0.5 mM NiCl~2~ for 4 months and then subjected to the soft agar assay. The cell colonies were counted by microscopy. Each bar indicates the mean and SD from triplicate assays. The symbol (\*) indicates a significant increase as compared with the medium control (*p* \< 0.05), while the symbol (♣) indicates a significant inhibition as compared with the Beas-2B(*Nonsense*) cells (*p* \< 0.05).

Activation of MTOR-ULK1-BECN1 autophagic cascade by nickel provides an inhibitory effect on SQSTM1 protein expression.

Autophagy is the basic catabolic mechanism that involves cell degradation of unnecessary or dysfunctional cellular components through the actions of lysosomes.[@cit0029] In addition, autophagy allows for the degradation and recycling of cellular components to promote cellular survival during starvation by maintaining cellular energy levels.[@cit0030] It has been reported that SQSTM1 is downregulated by an autophagy-mediated mechanism.[@cit0020] To elucidate the molecular mechanisms underlying SQSTM1 upregulation due to nickel exposure, the potential effect of nickel on cell autophagy was evaluated in Beas-2B cells exposed to nickel. The results unexpectedly showed that nickel exposure induced autophagy in Beas-2B cells as demonstrated by increases of accumulation of both LC3A-II and LC3B-II, 2 well-known autophagic markers ([Fig. 3A and 3B](#f0003){ref-type="fig"}). This notion was further supported by formation of GFP-LC3B puncta in Beas-2B(*GFP-LC3B*) transfectants following nickel exposure ([Fig. 3C](#f0003){ref-type="fig"}). The puncta could be observed as early as 3 h after nickel treatment, and the number of puncta constantly increased at 6 h and reached a peak at 12∼24 h ([Fig. 3D](#f0003){ref-type="fig"}). Consistently, the results from western blotting also indicated that the increases of exogenous GFP-LC3B-II and endogenous LC3B-II were observed in Beas-2B(*GFP-LC3B*) transfectants upon nickel treatment ([Fig. 3E](#f0003){ref-type="fig"}). Moreover, to assure this accumulation of LC3B-II was due to autophagy activation, the autophagy inhibitor 3-MA was employed as a pretreatment of cells prior to nickel exposure. The results revealed that 3-MA pretreatment inhibited the formation of LC3A-II and LC3B-II ([Fig. 4A and 4B](#f0004){ref-type="fig"}) and GFP-LC3B puncta (Fig. S4A) following nickel exposure in comparison to vehicle-treated cells. To confirm autophagic induction due to nickel exposure in Beas-2B, bafilomycin A~1~, a lysosomal inhibitor of autophagic flux,[@cit0031] was employed. As shown in [Figure 4C, 4D](#f0004){ref-type="fig"} and S4B, treatment of Beas-2B cells with bafilomycin A~1~ markedly increased levels of LC3A-II and LC3B-II, as well as GFP-LC3B puncta in comparison to those exposed to nickel alone. Similar autophagic induction was also observed in NHBECs and BEP2D cells following nickel exposure (Fig. S5). These results demonstrate that nickel exposure is able to efficiently induce autophagy in human bronchial epithelial cells. Figure 3.The induction of Beas-2B cell autophagy by nickel exposure. (A and B) 2 × 10^5^ Beas-2B cells were seeded into each well of 6-well plates. After the cell density reached 80∼90%, Beas-2B cells were treated with 1.0 mM NiCl~2~ for the indicated time (A) or with various concentrations of NiCl~2~ for 12 h (B). The cells were then extracted with SDS-sample buffer and cell extracts were subjected to western blot. (C) 1 × 10^4^ stable Beas-2B(*GFP*) and Beas-2B(*GFP-LC3B*) transfectants were seeded into each well of an 8-well chamber. After being cultured at 37°C for 48 h, the cells were exposed to 1.0 mM NiCl~2~ for the time indicated. The images were captured using fluorescence microscopy. The average GFP-LC3B puncta number were quantified and presented as puncta number/cell (D). The symbol (\*) indicates a significant increase as compared with the medium control (*p* \< 0.05). (E) 2×10^5^ Beas-2B(*GFP-LC3B*) transfectants were seeded into each well of 6-well plates and the cells were exposed to 1.0 mM NiCl~2~ for various time points, as indicated. The cell extracts were subjected to western blotting. Figure 4.The effects of 3-MA and bafilomycin A~1~ on the nicekl-induced LC3-II formation. (A and B) 2 × 10^5^ Beas-2B cells were seeded into each well of 6-well plates and the cells were pretreated with 3-MA (5.0 mM) for 30 min and then exposed to 1.0 mM NiCl~2~ for 6 h. The cell extracts were subjected to western blotting. The symbol (\*) indicates a significant increase as compared with the medium control (*p* \< 0.05), while the symbol (♣) indicates a significant inhibition as compared with nickel-treated alone (*p* \< 0.05). (C and D) 2 × 10^5^ Beas-2B cells were seeded into each well of 6-well plates and the cells were exposed to NiCl~2~ (1 mM) and bafilomycin A~1~ (Baf, 10 nM) for 6 h. The cell extracts were subjected to western blotting. The symbol (\*) indicates a significant increase as compared with the medium control (*p* \< 0.05), while the symbol (♣) indicates a significant increase as compared with the nickel-treated alone (*p* \< 0.05).

We next elucidated the signaling cascade leading to autophagy of Beas-2B cells due to nickel exposure. The autophagy-related (ATG) protein family and BECN1/Beclin1 are central proteins that regulate cell autophagy in many experimental systems.[@cit0032] We therefore determined the effect of nickel exposure on the expression of various ATG family members, including ATG3, ATG7, ATG12--ATG5 and BECN1. The results indicated that nickel exposure did not affect the expression of any of these proteins ([Fig. 5A](#f0005){ref-type="fig"}), suggesting that they might not be major players in nickel-induced autophagy. We further evaluated the nickel effects on activation of the MTOR cascade that regulates cell autophagy.[@cit0033] As shown in [Figure 5B](#f0005){ref-type="fig"}, MTOR phosphorylation at Ser2448, p-MTOR Ser2448, was dramatically inhibited at 3 h and thereafter following nickel exposure. Consistently, the phosphorylation of RPS6KB1/p70s6K and RPS6/S6 and EIF4EBP1/4E-BP1, which are regulated by MTOR, were also attenuated in similar patterns by nickel exposure ([Fig. 5B](#f0005){ref-type="fig"}). To test whether MTOR inhibition mediated autophagy due to nickel exposure, the dominant active mutant of *PIK3CA/p110*α, phosphoinositide 3-kinase (*PI3K*)*-DA*, was stably transfected into Beas-2B cells and the stable transfectant was used to evaluate the protective effect of the PI3K-MTOR cascade on nickel-induced autophagy. As shown in [Figure 5C](#f0005){ref-type="fig"}, activation of MTOR by PI3K-DA dramatically inhibited LC3B-II formation, suggesting that MTOR inhibition by nickel did play a role in nickel-induced cell autophagy. Figure 5.The important role of MTOR, ULK1, and BECN1 in mediation of cell autophagy upon nickel exposure in Beas-2B cells. (A, B and D) 2 × 10^5^ Beas-2B cells were seeded into each well of 6-well plates. After the cell density reached 80∼90%, the cells were exposed to 1.0 mM NiCl~2~ for the times indicated. The cell extracts were subjected to western blotting. (C) 2 × 10^5^ Beas-2B(*PI3K-DA*) and Beas-2B(*Vector*) transfectants were seeded into each well of 6-well plates. The cells were exposed to 1.0 mM NiCl~2~ for 6 h. The cell extracts were subjected to western blotting. (E and G) 2 × 10^5^ Beas-2B transfectants, as indicated, were seeded into each well of 6-well plates and the cells were exposed to 1.0 mM NiCl~2~ for 6 h (E) or various concentrations of NiCl~2~ for 6 h (G).The cell extracts were subjected to western blot and TUBA was used as protein loading control. (F and H) 2 × 10^5^ indicated Beas-2B transfectants were seeded into each well of 6-well plates and the cells were exposed to 1.0 mM NiCl~2~ and 10 nM of bafilomycin A1 (Baf) for 6 h. The cell extracts were subjected to western blot and ACTB was used as protein loading control.

It has been reported that ULK1 activation by inhibition of phosphorylation of ULK1 at Ser757 promotes cell autophagy.[@cit0034] We next investigated whether ULK1 could be involved in nickel-induced autophagy. As shown in [Figure 5D](#f0005){ref-type="fig"}, nickel exposure resulted in a dramatic reduction of phosphorylation of ULK1 at Ser757 in a time-dependent manner, suggesting that nickel did activate ULK1. In contrast, nickel treatment led to an increase in AKT phosphorylation with no observable alteration of PRKAA/AMPKα phosphorylation ([Fig. 5D](#f0005){ref-type="fig"}), excluding the possible association of AKT and PRKAA activation with either MTOR inhibition or ULK1 activation due to nickel exposure.

Given the ULK1 activation and cell autophagy following nickel exposure, we next evaluated the possible relationship between ULK1 activation and autophagy due to nickel exposure. To this end, the specific shRNA targeting *ULK1* was transfected into Beas-2B cells and the knockdown level of ULK1 in 2 clones of Beas-2B cells were determined, as shown in Figure S6A. The knockdown of *ULK1* expression impaired nickel-induced cell autophagy in Beas-2B cells ([Fig. 5E](#f0005){ref-type="fig"}). BECN1 acts downstream of ULK1 to regulate autophagy.[@cit0034] To identify whether BECN1 is involved in the regulation of nickel-activated autophagy, 4 *BECN1* shRNAs (\#1, \#2, \#3 and \#4) were stably transfected into Beas-2B cells (Fig. S6B). The results showed that shRNA-\#2 and -\#3 were able to markedly knockdown BECN1 protein expression (Fig. S6B). As expected, knockdown of *BECN1* expression attenuated the nickel-induced LC3B-II level ([Fig. 5G](#f0005){ref-type="fig"}). It was noted that nickel failed to increase the lysosome inhibitor bafilomycin A~1~-induced LC3B-II level in both transfectants of Beas-2B(*shULK1*) and Beas-2B(*shBECN1*), although marked LC3B-II induction was still observed in Beas-2B(*shULK1*) and Beas-2B(*shBECN1*) cells treated with bafilomycin A~1~ alone ([Fig. 5F and 5H](#f0005){ref-type="fig"}), revealing the specificity of inhibition of nickel-induced autophagy in Beas-2B(*shULK1*) and Beas-2B(*shBECN1*) transfectants. Collectively, our results demonstrate that nickel-induced autophagy requires inhibition of MTOR and activation of ULK1 and BECN1.

Nickel induced SQSTM1 transcription via a NFKB RELA-dependent axis {#s0002-0001}
------------------------------------------------------------------

To investigate the role of the autophagy cascade in regulation of nickel-induced SQSTM1 expression, the autophagy inhibitor 3-MA was employed. The disruption of autophagy by 3-MA markedly elevated the basal level and nickel-induced levels of SQSTM1 protein abundance ([Fig. 6A](#f0006){ref-type="fig"}). Consistently, inhibition of autophagy by either ectopic expression of PI3K-DA, or knockdown of *ULK1* or *BECN1* expression using their specific shRNAs also increased both basal and nickel-induced levels of SQSTM1 protein in Beas-2B cells ([Fig. 6B-6D](#f0006){ref-type="fig"}). Our results indicate that autophagy is a negative regulatory mechanism for SQSTM1 expression in Beas-2B cells. Figure 6.Autophagy induced by nickel inhibited the SQSTM1 level in human Beas-2B cells. (A) 2 × 10^5^ Beas-2B cells were seeded into each well of 6-well plates. The cells were pretreated with 5.0 mM 3-MA for 30 min and then exposed to 0.5 mM or 1.0 mM NiCl~2~ for 24 h. (B-D) 2 × 10^5^ of Beas-2B stable transfectants, including Beas-2B(*PI3K-DA*), Beas-2B(*shULK1*), Beas-2B(*shBECN1*), and their corresponding control vector transfectants as indicated, were seeded into each well of 6-well plates. After the cell density reached 80∼90%, the cells were exposed to 1.0 mM NiCl~2~ for 24 h. The cells were extracted with SDS-sample buffer and western blot was carried out as described in the "Materials and Methods." ACTB was used as a control for protein loading.

To determine the molecular mechanisms underlying nickel upregulation of SQSTM1 protein expression, we compared the effects of nickel on endogenous SQSTM1 protein and exogenous GFP-SQSTM1 protein expression. The results showed that nickel exposure specifically attenuated the exogenous GFP-SQSTM1 protein level, whereas overall it enhanced endogenous SQSTM1 protein abundance ([Fig. 7A](#f0007){ref-type="fig"}). Moreover, nickel exposure increased the SQSTM1 protein degradation rate in the presence of cycloheximide (CHX, a protein synthesis inhibitor) in comparison with cells treated with CHX alone ([Fig. 7B](#f0007){ref-type="fig"}). These results demonstrate that nickel could promote SQSTM1 protein degradation. Thus, we anticipated that nickel exposure would upregulate SQSTM1 protein, mainly at the mRNA level, although it promoted SQSTM1 protein degradation mediated by autophagy. To test this notion, Beas-2B cells were exposed to nickel to determine the effects of nickel on *SQSTM1* mRNA expression. The results from RT-PCR showed that nickel exposure resulted in a remarkable increase in *SQSTM1* mRNA in both time- and dose-dependent manners ([Fig. 7C-7E](#f0007){ref-type="fig"}). Further, we found that nickel treatment only showed a slight effect on exogenous *GFP-SQSTM1* mRNA expression, whereas it remarkably upregulated endogenous *SQSTM1* mRNA under same experimental conditions in Beas-2B(*GFP-SQSTM1*) transfectants ([Fig. 7F](#f0007){ref-type="fig"}). These results indicate that nickel is likely to upregulate SQSTM1 expression at the transcriptional level. Figure 7.Nickel induced *SQSTM1* transcription in Beas-2B cells. (A) 2×10^5^ stable Beas-2B(*GFP*) and Beas-2B(*GFP-SQSTM1*) transfectants, as indicated, were seeded into each well of 6-well plates. The cells were exposed to 1.0 mM NiCl~2~ for the indicated time points. The cells were extracted with SDS-sample buffer and western blot was carried out. ACTB was used as protein loading control. (B) Beas-2B cells were treated with CHX (50 μg/ml) together with or without NiCl~2~ for the indicated times. The cell extracts were subjected to analysis of SQSTM1 protein degradation rate by western Blotting. (C, E and F) Beas-2B cells were exposed to 1.0 mM NiCl~2~ for different time points, as indicated (C), or treated with the indicated doses of NiCl~2~ for 12 h (E). The stable Beas-2B(*GFP-SQSTM1*) cells were exposed to 1.0 mM of NiCl~2~ for the indicated time periods (F). The cells collected from (C-F) were extracted with Trizol reagent for total RNA isolation and RT-PCR was performed to determine *SQSTM1* or *GFP-SQSTM1* expression with their specific primers. *ACTB* was used as an internal control. (D) Real-time PCR was carried out to determine the *SQSTM1* mRNA expression using cDNA samples collected from Beas-2B cells exposed to 1.0 mM NiCl~2~ for 24 h obtained in (C). The symbol (\*) indicates a significant increase as compared with the medium control (*p* \< 0.05).

To evaluate this possibility, bioinformatics software was used to analyze the potential transcription factor binding sites in the *SQSTM1* promoter region. The results showed that there were multiple potential transcription factor binding sites in the *SQSTM1* promoter region, including those for JUN/AP-1, MYC/c-MYC, SP1, NFE2L2/NRF2, NFKB, and ETS1 ([Fig. 8A](#f0008){ref-type="fig"}). We then determined the effects of nickel on the nuclear translocation of these potential transcription factors using a nuclear/cytosol fractionation assay. The results indicated that nickel exposure led to the marked translocation of JUN/c-JUN and NFKB, whereas it did not show any observable effect on other transcription factors, including MYC, SP1 and NFE2L2 in Beas-2B cells ([Fig. 8B](#f0008){ref-type="fig"}). The lack of involvement of NFE2L2 in nickel-induced SQSTM1 was also supported by the results of testing the expression of NFE2L2-regulated genes HMOX1/HO-1 and NQO1. As shown (Fig. S7), mRNA induction of *HMOX1* and *NQO1* was observed in 24--36 h, but not within 12 h in nickel-exposed Beas-2B cells. Given that SQSTM1 protein upregulation by nickel exposure could be observed as early as 1 h following nickel exposure, excluding the possibility of NFE2L2 regulation of nickel-induced SQSTM1 expression. Although we noted that nickel upregulated ETS1 expression, the most of upregulated ETS1 protein was located in cytoplasm, suggesting that upregulated ETS1 protein might not act as a transcription factor in the nucleus. To identify the role of JUN and NFKB in nickel-induced SQSTM1 upregulation, dominant negative mutant *JUN* (TAM67) and *RELA* shRNA were stably transfected into Beas-2B cells. As shown in [Figure 8C-F](#f0008){ref-type="fig"}, the inhibition of *SQSTM1* mRNA expression was only observed in Beas-2B cells stably knocked down for RELA by using *RELA* shRNA ([Fig. 8D and 8F](#f0008){ref-type="fig"}), whereas the introduction of TAM67 had no observable effect on *SQSTM1* mRNA expression ([Fig. 8C and 8E](#f0008){ref-type="fig"}). Figure 8.RELA was a key transcription factor mediating *SQSTM1* transcription following nickel exposure. (A) Potential transcription factor binding sites in the *SQSTM1* promoter region (-1734∼+38) were analyzed using the TRANSFAC 8.3 engine online. (B) 2 × 10^5^ Beas-2B cells were seeded into each well of 6-well plates. The cells were exposed to 1.0 mM NiCl~2~ for the times indicated. The cell extracts were used to isolate cytoplasmic and nuclear fractions according to the protocol of the nuclear/cytosol fractionation kit. The isolated protein fractions were subjected to western blot. GAPDH and PARP were used as control for cytosol or nuclear protein loading, respectively. (C) Beas-2B(*Vector*) and Beas-2B(*TAM67*) cells were extracted with SDS-sample buffer and the cell extracts were analyzed by western blot with a specific anti-JUND antibody. (D) Stable Beas-2B(*shRELA*) and Beas-2B(*Nonsense*) cells were extracted with SDS-sample buffer and the cell extracts were analyzed by western blot with specific anti-RELA antibody. ACTB was used as a control for protein loading. (E and F) 2 × 10^5^ Beas-2B(TAM67) (E) or Beas-2B(*shRELA*) (F) cells and their corresponding vector transfectants were seeded into each well of 6-well plates. After the cell density reached 80∼90%, the cells were exposed to NiCl~2~ for 12 h and the cells were then extracted with Trizol reagent for total RNA isolation. *SQSTM1* was amplified with specific primers by RT-PCR. *ACTB* was used as an internal control. (G) 1×10^4^ Besa-2B cells transfected with *SQSTM1* full-length promoter-driven luciferase reporter (FL1) or NFKB-binding site-deleted *SQSTM1* promoter-driven luciferase reporter (FL2) were seeded into each well of 96-well plates. After being cultured overnight, the cells were treated with 1.0 mM NiCl~2~ for 24 h. The luciferase activity was then determined and the results are presented as *SQSTM1* promoter activity, relative to medium control. Each bar indicates the mean and SD of triplicate assay wells. The symbol (\*) indicates a significant increase in comparison to the medium control (*p* \< 0.05). The symbol (♣) indicates a dramatic decrease as compared to the Beas-2B cells transfected with FL1 (*p* \< 0.05). (H) 1 × 10^6^ Beas-2B cells were seeded into 100-mm dishes. After the cell density reached 80∼90%, the cells were exposed to 1.0 mM NiCl~2~ for 12 h. A ChIP assay was performed with anti-RELA antibody to determine RELA binding to the *SQSTM1* promoter as described in "Materials and Methods."

To provide direct evidence showing whether or not RELA regulated *SQSTM1* transcription, we transfected either a full-length *SQSTM1* promoter-driven luciferase reporter or short length *SQSTM1* promoter-driven luciferase reporter lacking NFKB binding sites into Beas-2B cells (Fig. S8). As shown in [Figure 8G](#f0008){ref-type="fig"}, the promoter transcription activation was inhibited in the promoter with deletion of NFKB binding sites in comparison to the cells transfected with the full-length *SQSTM1* promoter reporter. Moreover, a ChIP assay was performed to determine whether RELA could directly bind to the *SQSTM1* promoter region that contains tentative RELA binding sites. The results showed that nickel exposure significantly increased RELA protein binding to the tentative DNA fragment ([Fig. 8H](#f0008){ref-type="fig"}), revealing that RELA did bind to the *SQSTM1* promoter region in nickel-exposed cells. Taken together, our results conclusively demonstrate that NFKB RELA activation plays an important role in nickel-induced SQSTM1 transcription and protein expression in Beas-2B cells.

SQSTM1 upregulation contributes to an increase in inflammatory TNF/TNFα by nickel {#s0002-0002}
---------------------------------------------------------------------------------

Chronic lung inflammation is a potent force for driving development of lung cancers.[@cit0035] As shown above, our results demonstrate that SQSTM1 is important for nickel-induced transformation of Beas-2B cells. These results prompted us to determine the potential relationship between SQSTM1 upregulation and lung inflammatory responses upon nickel exposure. The results showed that knockdown of *SQSTM1* expression reduced *TNF* mRNA level following nickel exposure ([Fig. 9A](#f0009){ref-type="fig"}), whereas ectopic expression of GFP-SQSTM1 remarkably upregulated *TNF* levels induced by nickel exposure ([Fig. 9B](#f0009){ref-type="fig"}). Consistent with RELA regulation of *SQSTM1*, knockdown of *RELA* also attenuated the *TNF* mRNA level following nickel exposure, whereas introduction of GFP-SQSTM1 could restore the *TNF* mRNA level upon nickel exposure in *RELA* knockdown cells ([Fig. 9C-9E](#f0009){ref-type="fig"}). To elucidate the molecular mechanism underlying SQSTM1 upregulation of *TNF* expression, the *TNF* promoter-driven transcription activity and *TNF* mRNA stability were evaluated in Beas-2B(*shSQSTM1*) transfectants in comparison to Beas-2B(*Nonsense*) transfectants following nickel exposure. As shown in [Figure 9F and 9G](#f0009){ref-type="fig"}, knockdown of *SQSTM1* only showed a slight effect on nickel-induced *TNF* promoter transcriptional activity ([Fig. 9F](#f0009){ref-type="fig"}), whereas it markedly reduced nickel-induced *TNF* mRNA stability ([Fig. 9G](#f0009){ref-type="fig"}). Further, ectopic expression of GFP-SQSTM1 significantly increased nickel-induced *TNF* mRNA stability ([Fig. 9H](#f0009){ref-type="fig"}). These results reveal that SQSTM1 mediates *TNF* mRNA abundance mainly through enhancing its mRNA stability. The results from determination of TNF protein in cell cultured medium indicated that SQSTM1-mediated stabilization of *TNF* mRNA following nickel exposure resulted in increased TNF release into the culture medium (Fig. S9). Moreover, inhibition of nickel-induced autophagy by 3-MA or knockdown of *BECN1* could promote *TNF* mRNA abundance by nickel exposure ([Fig. 9I and 9J](#f0009){ref-type="fig"}). Collectively, these results clearly demonstrate that RELA-mediated SQSTM1 upregulation plays an essential role in the increased *TNF* abundance upon nickel exposure, whereas autophagy exerts an inhibitory effect on *TNF* level following nickel exposure. Figure 9.SQSTM1 upregulation contributed to inflammatory *TNF* induction by nickel. (A-C and J) 2 × 10^5^ Beas-2B transfectants, as indicated, were seeded into each well of 6-well plates. After the cell density reached 80∼90%, the cells were exposed to 1.0 mM NiCl~2~ for 24 h. Cells were extracted with Trizol reagent for total RNA isolation. Real-time PCR was carried out to monitor the *TNF* mRNA. (D and E) *GFP-SQSTM1* or its control vector was transfected into Beas-2B(*shRELA*) cells. Cell extracts were subjected to western Blot for determination of protein expression as indicated (D). 2×10^5^ transfectants were seeded into each well of 6-well plates. The cells were then exposed to 1.0 mM NiCl~2~ for 24 h, and nickel-induced *TNF* mRNA was evaluated by real-time PCR (E). (F) 8 × 10^3^ Beas-2B (*Nonsense/TNF-Luc*) cells and Beas-2B (*shSQSTM1-\#1*/*TNF*-Luc) cells were seeded into each well of a 96-well plate. After being cultured at 37°C overnight, the cells were exposed to 1.0 mM nickel for 24 h. The luciferase activity was measured. (G and H) *TNF* mRNA degradation rate in Beas-2B cell transfectants was determined following nickel treatment in the presence of actinomycin D (RNA synthesis inhibitor, 10 μM) for the indicated time. (I) Beas-2B cells were pretreated with 5.0 mM 3-MA for 30 min and then exposed to 1.0 mM NiCl~2~ for 24 h. The cells were extracted with Trizol reagent for total RNA isolation and then subjected to real-time PCR. The symbol (\*) indicates a significant increase (*p* \< 0.05), while the symbol (♣) indicates a significant decrease (*p* \< 0.05).

TNF induction mediates cell malignant transformation of human bronchial epithelial cells following nickel exposure.

Our previous studies demonstrate that TNF induction is critical for B\[a\]PDE-induced cell transformation in vitro in mouse epidermal Cl41 cells and human lung epithelial Beas-2B cells.[@cit0036] Our above results also indicate that SQSTM1 is important for nickel-induced cell malignant transformation and TNF levels in Beas-2B cells. Thus, we determined the role of TNF induction in malignant transformation of human lung bronchial epithelial cells upon nickel exposure. The results showed that the knockdown of *TNF* in Beas-2B or BEP2D cells, by stable transfection of *TNF*-specific shRNA-\#3 and shRNA-\#4, as shown in [Figure 10A](#f0010){ref-type="fig"} and Fig. S10A, dramatically inhibits transformation of either Beas-2B cells ([Fig. 10B and 10C](#f0010){ref-type="fig"}) or BEP2D cells (Fig. S10B and S10C) following nickel-repeated exposure in comparison to their nonsense transfectants, revealing that TNF induction plays an important role in nickel-induced transformation of human bronchial epithelial cells. Consistently, the stable knockdown of *BECN1* expression in Beas-2B cells also significantly increased nickel-induced cell transformation of Beas-2B ([Fig. 10D and 10E](#f0010){ref-type="fig"}), further demonstrating that TNF induction is important for nickel-induced malignant transformation of human bronchial epithelial cells. Figure 10.TNF induction mediated cell transformation of Beas-2B cells due to nickel exposure. (A) Specific *TNF* shRNAs were stably transfected into Beas-2B cells. The cells were extracted with Trizol reagent for total RNA isolation. *TNF* was amplified with its specific primers by RT-PCR. *ACTB* was used as an internal control. (B and C) Beas-2B(*Nonsense*), Beas-2B(*shTNF-\#3*), and Beas-2B(*shTNF-\#4*) cells were repeatedly treated with 0.5 mM NiCl~2~ for 6 months, then 1×10^4^ cells were subjected to a soft agar assay as described in "Materials and Methods." The cell colonies were counted by microscopy. Each bar indicates the mean and SD from triplicate assays. The symbol (\*) indicates a significant increase as compared to that of the medium control (*p* \< 0.05), while the symbol (♣) indicates a dramatic decrease compared with Beas-2B(*Nonsense*) (*p* \< 0.05). (D and E) Beas-2B(*Nonsense*), Beas-2B(*shBECN1-\#2*), and Beas-2B(*shBECN1-\#3*) cells were repeatedly treated with 0.5 mM NiCl~2~ for 4 months. 1 × 10^4^ treated cells were subjected to a soft agar assay. The symbol (\*) indicates a significant increase in comparison to Beas-2B(*Nonsense*) (*p* \< 0.05). (F) A novel molecular mechanisms underlying SQSTM1 induction and its role in malignant transformation of human bronchial epithelial cells following nickel exposure. The symbol (\*) indicates a significant increase (*p* \< 0.05), while the symbol (♣) indicates a significant decrease (*p* \< 0.05).

Discussion {#s0003}
==========

Chronic exposure to the inorganic nickel compounds occurs not only in environmental air pollution and occupational workers, but also in tobacco smokers.[@cit0009] The major medical problem caused by nickel exposure is chronic lung inflammation.[@cit0038] Since nickel compounds do not show high affinity for DNA,[@cit0011] it is accepted that non-genotoxic mechanisms are responsible for their carcinogenic activity. Chronic lung inflammation caused by nickel exposure is most frequently associated with the development of lung cancer.[@cit0038] The link between nickel-caused chronic inflammation to lung carcinogenesis was observed as early as 30 y ago,[@cit0041] and has been verified in animal studies.[@cit0039] However, the molecular mechanisms by which nickel-initiated lung inflammation leads to lung cancer development largely remain unknown. Here, we discover a novel RELA-SQSTM1 axis that enhances *TNF* mRNA stability and expression, which promotes cell transformation following nickel exposure. Concurrently, nickel exposure activates the MTOR-ULK1-BECN1 autophagic cascade, subsequently causing SQSTM1 protein degradation, which exhibits an inhibitory effect on cell transformation upon nickel exposure. Our findings not only identify SQSTM1 as a new target for nickel initiation of lung tumorigenic effects, they also provide a novel scenario linking SQSTM1 and autophagy to the regulation of lung inflammation and malignant cell transformation upon environmental nickel exposure, as shown in [Figure 10F](#f0010){ref-type="fig"}.

Although SQSTM1 has been reported to be overexpressed in cancer tissues,[@cit0025] SQSTM1 induction and its contribution to environmental carcinogens has never been explored. We found that nickel exposure was able to upregulate SQSTM1 protein level in Beas-2B, BEP2D and NHBEC cells. This upregulation was also observed in the lung tissues of mice exposed to nickel. Consistent with these findings observed in nickel exposure in an in vitro cell culture model and in an in vivo mouse model, the results obtained from some human lung cancer tissues also displayed the SQSTM1 upregulation in comparison to those in the paired adjacent normal lung tissues. Of greatest importance is that our results demonstrate that SQSTM1 upregulation is important for nickel-induced malignant transformation of human bronchial epithelial cells ([Fig. 2](#f0002){ref-type="fig"}), cancer marker CCND1 (cyclin D1) and CCNE1 (cyclin E1) expression (Fig. S11A), and cell migration (Fig. S11B and S11C). Thus, our studies not only show, for the first time, that SQSTM1 is induced following nickel exposure, but also demonstrate the contribution of SQSTM1 upregulation to nickel\'s lung carcinogenic effects.

SQSTM1 protein expression is regulated at multiple levels, including protein degradation and mRNA transcription.[@cit0043] Autophagy is an important cell biological function that could help cell in degrading unnecessary or dysfunctional cellular components through the actions of lysosomes.[@cit0029] SQSTM1 is a receptor and substrate of autophagy, and autophagy defects lead to accumulation of SQSTM1 protein.[@cit0020] In the current studies, we evaluated the effects of nickel on cell autophagy and unexpectedly found that nickel activated autophagy rather than inhibited cell autophagy in Beas-2B cells. Remarkably induction of LC3A-II and LC3B-II, and GFP-LC3B puncta was observed in Beas-2B cells exposed to nickel, whereas the pretreatment of cells with the autophagy inhibitor 3-MA impaired nickel-induced formation of GFP-LC3B puncta in Beas-2B cells under the same experimental conditions (Fig. S4). We also found that nickel exposure induced autophagy of Beas-2B cells via inhibition of MTOR, which in turn activated the ULK1-BECN1 autophagic cascade. Our results showed that ectopic expression of activated-PI3K or knockdown of *ULK1* or *BECN1* expression dramatically inhibited nickel-induced autophagy, accompanied by the accumulation of GFP-SQSTM1 protein expression, revealing that autophagy induced by nickel exposure promoted SQSTM1 protein degradation. It is of great interest to note that nickel exposure inhibits endogenous SQSTM1 protein expression, which is different from previous findings that arsenite upregulates SQSTM1 expression through inhibiting cell autophagy.[@cit0045] Moreover, we found that ectopic expression of activated-PI3K or knockdown of *ULK1* or *BECN1*, dramatically inhibited nickel-induced autophagy and elevated nickel-induced SQSTM1 protein expression, revealing that nickel-induced autophagy negatively regulates SQSTM1 protein expression following nickel exposure.

We found that the final outcome of nickel-upregulated SQSTM1 protein expression resulted from mRNA induction, which overcame SQSTM1 protein degradation mediated by autophagy due to nickel exposure. The exploration of the mechanisms underlying nickel regulation of *SQSTM1* mRNA showed that nickel upregulated *SQSTM1* mRNA due to *SQSTM1* promoter transcriptional activation, as demonstrated using a *SQSTM1* promoter-driven luciferase reporter that had been cloned from Beas-2B genomic DNA, as shown in Fig. S8. By analyzing the *SQSTM1* promoter, we observed multiple transcription binding sites, including NFE2L2, SP1, ETS1, JUN, MYC and NFKB. NFE2L2 has been reported as enhancing tumor growth in some cancer tissues by upregulating *SQSTM1* transcription,[@cit0046] whereas SP1 has been reported as regulating *SQSTM1* promoter activity following H~2~O~2~ treatment in HEK293 cells.[@cit0047] The results from our studies showed that nickel exposure did not induce expression and nuclear translocation of either NFE2L2 or SP1. The SQSTM1 overexpression in breast tumors and regulation by prostate-derived ETS1 factor in breast cancer cells has been reported.[@cit0042] The results from our studies indicated that nickel exposure only induced a slightly nuclear translocation, although ETS1 expression was inducible in nickel-treated Beas-2B cells, suggesting that ETS1 might not be a major transcriptional factor mediating *SQSTM1* transcription. A potential MYC binding site has also been observed in the *SQSTM1* promoter, however, nickel failed to induce MYC nuclear translocation in Beas-2B cells. Our previous studies demonstrate that nickel exposure is able to activate JUN and NFKB in Beas-2B cells and the results from the current studies consistently indicated that nuclear translocation of both transcription factors was observable in Beas-2B cells exposed to nickel. We further found that blockage of JUN activation by ectopic expression of a dominant negative *JUN* mutant (*TAM67*)[@cit0048] did not show any observable effect on *SQSTM1* mRNA induction in Beas-2B cells following nickel exposure, whereas knockdown of *RELA* expression dramatically attenuated *SQSTM1* mRNA induction under the same experimental conditions, demonstrating that RELA plays an important role for *SQSTM1* transcriptional induction following nickel exposure. The results from ChIP assay showed that nickel-activated RELA is able to bind to the *SQSTM1* promoter sequence. Therefore our results, for the first time, identify RELA acting as a key transcription factor binding to the *SQSTM1* promoter and initiating *SQSTM1* transcription. This notion is consistently supported by the findings obtained from in vivo studies showing that RELA phosphorylation at Ser536 is markedly increased in mouse lung tissues following nickel inhalation (Fig. S12).

Growing evidence indicates that a chronic inflammatory microenvironment in the lung is a major driving force for the development of lung cancers.[@cit0015] At least 10 cohort studies have shown that chronic obstructive pulmonary disease is an independent predictor of lung cancer risk.[@cit0051] Following a short period of silica exposure, type-2 pneumocytes and bronchiolar epithelial cells become hyperplastic. The subsequent appearance of adenomas is followed by the appearance of adenocarcinomas and then squamous cell carcinomas. The progression from inflammatory granuloma to lung carcinoma in this model clearly points to the important role of inflammation in human lung carcinogenesis.[@cit0053] The strong association between airway inflammation and susceptibility to lung cancer was confirmed by epidemiological and clinical studies.[@cit0054] The chronic inflammation microenvironment is predominated by macrophages,[@cit0049] which together with other leukocytes, may generate high levels of reactive oxygen and nitrogen species, and eventually may cause DNA damage and the activation of signaling pathways that lead to cancer-associated gene expression.[@cit0009] In addition, the cells in the inflammatory site may release TNF, which plays a regulatory role in growth and the inhibition of apoptosis.[@cit0057]

The link between nickel-caused chronic inflammation to lung carcinogenesis was observed as early as 30 y ago[@cit0041] and has been verified in animal studies.[@cit0039] Our recent studies have shown that nickel exposure induces the activation of the key inflammatory transcription factor NFKB, which in turn leads to the induction of the key inflammatory mediator PTGS2/COX-2 expression, subsequently protecting nickel-treated HBECs from apoptosis.[@cit0059] Our published studies also show that nickel exposure leads to JUN activation, NFAT activation and TNF expression in Beas-2B cells.[@cit0060] The results from the current studies revealed that SQSTM1 expression played an important role in TNF induction by nickel exposure mainly through upregulating *TNF* mRNA stability, which further promoted nickel-induced cell transformation. Moreover, SQSTM1 protein increase by inhibition of autophagy with either 3-MA or knockdown of *BECN1* also enhanced the *TNF* mRNA level following nickel exposure. Our studies further demonstrate that TNF induction is essential for nickel-induced malignant transformation of human bronchial epithelial cells ([Fig. 10B and 10C](#f0010){ref-type="fig"}), increased expression of cell growth markers CCND1 and CCNE1 (Fig. S11D), and promotion of cell migration (Fig. S11E and S11F). This notion was supported by finding that the increased *TNF* mRNA level in *BECN1* knockdown cells also promoted nickel-induced Beas-2B cell transformation. It has been reported that NFKB acts as a key SQSTM1 downstream target that is responsible for TNF expression.[@cit0061] Our previous studies also indicate that TNF could be a feedback player in the activation of NFKB.[@cit0062] Given our previous studies demonstrating that JUN is important for nickel-induced *TNF* transcription, we anticipate that the TNF induction mediated by both JUN-dependent transcription and RELA-SQSTM1-dependent mRNA stability will promote and maintain the sustained inflammatory microenvironment as schematically depicted in [Figure 10F](#f0010){ref-type="fig"}.

In the current studies, we determined the potential molecular mechanisms underlying SQSTM1-mediated stabilization of *TNF* mRNA. As shown in Figure S13, knockdown of *SQSTM1* did not affect expression of NCL (nucleolin) and ELAVL1/HUR, both of which have been reported to regulate their targeted mRNA stability.[@cit0063] Since MAPK14/p38 and MAPK1/ERK2-MAPK3/ERK1 activation has also been reported to be involved in the modulation of *TNF* mRNA stability,[@cit0065] we also evaluated the effect of knockdown of *SQSTM1* expression on activation of MAPK14 and MAPK1/3. The results did show that knockdown of *SQSTM1* led to an inhibition of MAPK14 and MAPK1/3 phosphorylation as compared to these observed in Beas-2B(*Nonsense*) transfectants, suggesting their possible involvement in SQSTM1-mediated regulation of *TNF* mRNA stability. The studies toward this direction as well as elucidation of how MAPK14 and MAPK1/3 activation lead to *TNF* mRNA stabilization is a current ongoing project in our group.

In summary, our current studies, for the first time, discover SQSTM1 upregulation by the environmental lung carcinogen nickel both in vitro and in vivo via a RELA-dependent pathway, and demonstrate the essential role of this SQSTM1 upregulation in nickel-induced malignant transformation of human bronchial epithelial cells. We have also identified a novel signaling cascade underlying SQSTM1s incentive modulation of TNF upregulation following nickel exposure. The results from these current studies clearly demonstrate the formation of inflammatory positive feedback loops by NFKB RELA, SQSTM1 and TNF, as well as providing evidence that SQSTM1-autophagy are essential regulators of the entire nickel-induced tumorigenic network. The current studies facilitate our understanding of the molecular mechanism(s) underlying SQSTM1 upregulation and its role in lung cancer development due to nickel exposure. Such novel information will spur the efficacious development of preventive and therapeutic approaches that specifically target SQSTM1.

Materials and methods {#s0004}
=====================

Chemical reagents {#s0004-0001}
-----------------

NiCl~2~ (451193) and Ni(OH)~2~ (283622) were purchased from Sigma Aldrich Corporation. The autophagy inhibitor 3-MA (189490) was bought from Calbiochem. PolyJet^TM^ DNA In Vitro Transfection Reagent (SL100468) was purchased from SignaGen Laboratories. TRIzol reagent (15596026) and SuperScript^TM^ First-Strand Synthesis system (18080051) were bought from Invitrogen Corporation. The dual luciferase assay kit (E1960) was purchased from Promega Corporation. The nuclear/cytosol fractionation kit (K266--100) was obtained from Biovision Incorporated.

Plasmids {#s0004-0002}
--------

The shRNA plasmids specifically targeting *SQSTM1* (human, RHS3979-201739507), *BECN1* (human, RHS3979-201763046), and *RELA* (human, RHS3979-201746261) were purchased from Open Biosystems, Inc. Another set of shRNA plasmids that target human *TNF* (TRCN0000003757) was bought from Sigma Aldrich Corporation. *GFP-LC3B* and its control vector were a kind gift from Dr. Gang Chen (University of Kentucky, Lexington, KY, USA),[@cit0066] and the *GFP-SQSTM1* expression construct was from Dr. Sung Ouk Kim (University of Western Ontario, London, Ontario, Canada).[@cit0067] Dominant active mutant *PI3K* expression plasmid, *PI3K-DA* was from Dr. Lewis T. Williams (University of California, San Francisco, CA, USA).[@cit0068] The shRNA targeting *ULK1* expression construct was obtained from Addgene (27633, Reuben Shaw Lab).[@cit0069] The plasmid of *TNF* promoter-driven luciferase reporter, dominant negative *JUN* plasmid (*TAM67*), was used as described in our previous studies.[@cit0048]

*SQSTM1* promoter (full length, from −1734 to +38)-driven luciferase reporter was constructed using genomic DNA purified from Beas-2B cells based on the NCBI database. Nested PCR was carried out. The forward outside primer sequence was (F1): 5′-CCT ATT ACG ACA GCG GTC ATG G-3′ and the reverse primer was (R1): 5′-AGC TGG CGG AAA ACG GG-3′. The PCR product was next used for subsequent PCR using the nested forward primer (F2): 5′-GGA AGA TCT CTG ACT CAC TGC CGG CCA GAC-3′ containing a BglII restriction site and the reverse primer (R2): 5′-CCC AAG CTT TGT AGC GAA CGC GGA GGC-3′ containing a HindIII restriction site. To construct a NFKB binding site deletion promoter (short, from −1656 to +38) the nested forward primer of (F3): 5′-GGA AGA TCT GTT TAC CTC CGG GAG GCC TCG-3′ was used. The PCR product was digested and cloned into the pGL3-Basic vector (Promega, E1751) and verified by DNA sequencing.

Cell culture and transfection {#s0004-0003}
-----------------------------

Beas-2B cells were cultured at 37°C with 5% CO2 in Dulbecco\'s modified Eagle\'s medium (DMEM; 11995065) supplemented with 10% fetal bovine serum (FBS; 26140079), 1% penicillin/streptomycin (15140163), 2 mM L-glutamine (25030164), all from Life Technologies.[@cit0048] NHBECs were cultured as described in a previous study.[@cit0071] BEP2D cells were cultured as described in a previous study.[@cit0028] Cell transfection was performed using PolyJet^TM^ DNA In Vitro Transfection Reagent, according to the manufacturer\'s instruction. Twenty-four h after transfection, the transfected cells including Beas-2B(*shSQSTM1*), Beas-2B(*shBECN1*), Beas-2B(*shTNF*), Beas-2B(*shRELA*), and Beas-2B(*shULK1*) were subjected to puromycin (0.3 µg/ml) (Alexis, BML-A260-0050) for stable selection, while Beas-2B(*GFP-SQSTM1*) and its control cell lines were selected for over 3 weeks in 10% FBS DMEM containing G418 (1000 μg/ml; Invitrogen, 10131027). The stable transfectants were cultured in the selective drug-free medium for at least 2 passages before being used for each experiment.

RT-PCR {#s0004-0004}
------

Cells were exposed to nickel for the indicated time points, and then 5.0 μg total RNA was used for first-strand cDNA synthesis with oligodT (20) primer by SuperScript^TM^ First-Strand Synthesis system (Invitrogen, 11904018).[@cit0072] The *SQSTM1* and *TNF* were monitored by PCR. The results were imaged with Α Innotech SP image system (Α Innotech Corporation, San Leandro, CA, USA). Three pairs of oligonucleotides (Forward: 5′- GAG AGT GTG GCA GCT GCC CT-3′, Reverse: 5′-GGC AGC TTC CTT CAG CCC TG-3′; Forward: 5′-GTG ATC GGC CCC CAG AGG GA-3′ Reverse: 5′-ACT GGA GCT GCC CCT CAG CTT-3′and Forward: 5′- CGC CGA CCA CTA CCA GCA GAA-3′, Reverse: 5′-CAC ACG GTG GGC GGT GGT CC-3′) were used as the specific primers to amplify human *SQSTM1* (420 base pairs \[bp\]), human *TNF* (148 bp) and *GFP-SQSTM1* (550 bp). *ACTB/*β*-Actin* (268 bp) (Forward: 5′-CTC CAT CCT GGC CTC GCT GT-3′, Reverse: 5′-GCT GTC ACC TTC ACC GTT CC-3′) was used as a loading control.

Quantitative RT-PCR {#s0004-0005}
-------------------

Real-time PCR was conducted following the protocol for Fast SYBR Green Master Mix kit (Applied Biosystems, 4385614) in the 7900HT Fast Real-Time PCR System (Applied Biosystems, Foster City, CA, USA) using the same cDNAs that were used for RT-PCR.

Western blot {#s0004-0006}
------------

The antibodies specific against JUN (9165S), JUND (5000S), P-JUN Ser63 (2361S), P-JUN Ser73 (9164S), AKT (9272S), p-AKT Ser473 (9271S), RELA (8242S), PIK3CA (4255S), PARP (9542S), GAPDH (5174S), NFE2L2 (12721S), MTOR Pathway Antibody Sampler Kit (9964S), Autophagy Antibody Sampler Kit (4445S), RPS6KB1 Substrates Antibody Sampler Kit (2903S) and ULK1 Antibody Sampler Kit (8359T) were purchased from Cell Signaling Technology. Antibodies to GFP (sc-390394), ETS1 (sc-55581), SP1 (sc-14027) and MYC (sc-788) were bought from Santa Cruz Biotechnology. Antibodies that are specific against NFKB1 (ab32360) and SQSTM1 (ab155686) were bought from Abcam. Antibodies against ACTB (A1978) and TUBA/α-tubulin (T6199) were bought from Sigma Aldrich Corporation. Western blotting was performed as described in our previous publication.[@cit0073]

Animal experiments and lung tissue sample preparation {#s0004-0007}
-----------------------------------------------------

Male C57BL/6J mice were obtained from Taconic Farms (Germantown, NY) and housed, as described in our previous publication.[@cit0075] All procedures involving animals were conducted in compliance with guidelines for ethical animal research and approved by the New York University School of Medicine Animal Care and Use Committee. Nickel nanoparticles were generated by electricarc discharge (Palas GmbH) between 2 opposing high-purity rods (99.995% purity, ESPI, Ashland, OR) in an ultra pure argon chamber. One mg/m3 of Nano-Ni(OH)~2~ exposure was performed as described previously.[@cit0024] The mice were sacrificed at different periods, as indicated, and the lung tissues were extracted with SDS-sample buffer (10 mM Tris-HCl, pH 7.4, 1% SDS \[Thermo Fisher Scientific Inc., BP16650\], 1 mM Na~3~VO~4~, containing 2 × complete protease inhibitor \[Roche, 04693116001\]) and kept on ice for 2 h. The extracts were then sonicated and denatured by heating at 100°C for 5 min, and quantified with a Dc protein assay kit (Bio-Rad, 5000116). Equal aliquots of mouse lung tissue extracts were subjected to protein gel blot for protein analysis.

The clinical specimens used in the current study were lung squamous cell carcinomas as shown Table S1, which were obtained from the First Affiliated Hospital of Wenzhou Medical University (Wenzhou, Zhejiang, China) with appropriate informed consent from the patients and a supportive grant obtained from the Medical Ethics Committee of Wenzhou Medical University. Adjacent normal lung tissue specimens were taken from a standard distance (3 cm) from the margin of resected neoplastic tissues of patients with tumors who endured surgical lung ablation. Specimens were examined by pathologists,[@cit0037] and then frozen at −80°C until shipment on dry ice. The protein extracts were prepared using the same protocol for mouse lung tissues, and then subjected to western blot for determination of SQSTM1 expression.

Luciferase reporter assay {#s0004-0008}
-------------------------

*SQSTM1* promoter driven-luciferase or *TNF* promoter-driven luciferase reporter plasmids were transiently transfected into cells. The transfectants were seeded into each well of 96-well plates (8×10^3^ cells per well) and subjected to the various treatments, as described in our previous study.[@cit0076] Luciferase activities were determined with the Dual-Luciferase Reporter Assay System using a luminometer as described previously.[@cit0077]

Fluorescence microscopy {#s0004-0009}
-----------------------

Beas-2B cell transfectants were cultured on cover slides in 10% FBS DMEM medium for 48 h. The cells were exposed to 1.0 mM nickel for the indicated time and fixed with 4% paraformaldehyde (Sigma Aldrich Corporation, 158127) in PBS (135 mM NaCl, 4.7 mM KCl, 10 mM Na~2~HPO~4~, 2.0 mM NaH~2~PO~4~, pH 7.4) at room temperature for 15 min, and then stained with 0.1 mg/ml DAPI (Sigma Aldrich Corporation, 9542) for 1 min. The slides were washed 3 times with PBS and mounted with antifade reagent (Molecular Probes, P36930). All the cell images were captured using an inverted Leica fluorescence microscope (Wetzlar, Germany). For quantification of autophagic cells, GFP-LC3B puncta were determined by counting at least 30 cells per slide.[@cit0022]

Chromatin immunoprecipitation (ChIP) assay {#s0004-0010}
------------------------------------------

ChIP was performed as described in our previous publication.[@cit0078] Briefly, Beas-2B cells were treated with 1.0 mM nickel for 12 h. Then genomic DNA and proteins were cross-linked with 1% formaldehyde. The complex was sonicated to generate 200- to 500-bp chromatin DNA fragments. The chromatin was then subjected to immunoprecipitation using antibodies specific to RELA. After immunoprecipitation, the protein-DNA cross-links were used to extract DNA and then subjected to PCR analysis. The following pair of primers: 5′-CCT ATT ACG ACA GCG GTC ATG-3′ and 5′-ACA CCC GGC TCT GGC CCT TC-3′ was used to amplify 195-bp fragments which contains RELA binding sites in the *SQSTM1* promoter. The PCR products were separated on 2% agarose gels and the images were captured under UV light with the Α Innotech SP image system.

Cell transformation {#s0004-0011}
-------------------

Cell transformation was performed as described in our studies previously.[@cit0079] For the first 2 mo of nickel exposure, Beas-2B cells or BEP2D cells were exposed to 0.5 mM nickel for 24 h following which nickel-containing medium was replaced with fresh 10% FBS DMEM and cultured for 48 h. We continued to treat the nickel-exposed cells with 0.5 mM nickel for 12 h at which point the nickel-containing medium was replaced with fresh 10% FBS DMEM and cultured for 60 h. The cultures were split and subjected to another round of treatment. The described nickel exposure was repeated twice a wk for 4--6 mo when the anchorage-independent growth capability of the treated cells was subjected to soft agar assay.

Soft agar assay {#s0004-0012}
---------------

The anchorage-independent growth ability of the nickel-treated Beas-2B cells was evaluated in soft agar, as described in our previous study.[@cit0080] Briefly, 3 ml of 0.5% agar (Becton, Dickinson and Company, 214010) in basal modified Eagle\'s medium supplemented with 10% FBS was layered onto each well of 6-well tissue culture plates. Cells (1×10^4^ cells) suspended in 1 ml of normal medium (Sigma-Aldrich Corporation, B9638) were mixed with 2 ml of 0.5% agar in basal modified Eagle\'s medium supplemented with 10% FBS; 1 ml of mixture was added into each well on top of the 0.5% agar layer. Plates were incubated at 37°C in 5% CO~2~ for 3 wk, and the colonies were scored and presented as colonies/10^4^ cells.

Statistical methods {#s0004-0013}
-------------------

Statistical analysis was performed using Prism 5.0 Software (Graph-pad software, San Diego, CA, USA). Student *t* test was employed to determine the significance of differences between various groups. The differences were considered significant at *p* \< 0.05.
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Abbreviations
=============

Act D

:   actinomycin D

ATG

:   autophagy-related

CHX

:   cycloheximide

FBS

:   fetal bovine serum

LC3

:   microtubule associated protein 1 light chain 3

NHBEC

:   normal human bronchial epithelial cell

NSCLC

:   non-small cell lung carcinoma

PI3K

:   phosphoinositide 3-kinase

SCLC

:   small cell lung carcinoma

shRNA

:   short hairpin RNA

SQSTM1/p62

:   sequestosome 1

3-MA

:   3-methyladenine
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